{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:42:54Z","timestamp":1791236574044,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais (BR)","doi-asserted-by":"publisher","award":["CBB-APQ-01225-11\/02007-12"],"award-info":[{"award-number":["CBB-APQ-01225-11\/02007-12"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["480979\/2013-8"],"award-info":[{"award-number":["480979\/2013-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["482249\/2012-9"],"award-info":[{"award-number":["482249\/2012-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais (BR)","doi-asserted-by":"publisher","award":["CBB-02076-10\/02473-10\/01052-11\/01698-12\/02372-13\/03576-13\/00609-15"],"award-info":[{"award-number":["CBB-02076-10\/02473-10\/01052-11\/01698-12\/02372-13\/03576-13\/00609-15"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13071-016-1752-6","type":"journal-article","created":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T10:37:01Z","timestamp":1472553421000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Multicomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec\u00ae and Leishmune\u00ae vaccines against visceral leishmaniasis"],"prefix":"10.1186","volume":"9","author":[{"given":"Ludmila Zanandreis","family":"de Mendon\u00e7a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilene Aparecida","family":"Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Ferreira","family":"Lanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Dian de Oliveira","family":"Aguiar-Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Mendes","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Alves de Oliveira e","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edcio Azevedo","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Silveira-Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana de Assis Silva","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Toshio","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Aparecida","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Corr\u00eaa-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walderez Ornelas","family":"Dutra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Barbosa","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo Cordeiro","family":"Giunchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,30]]},"reference":[{"issue":"8","key":"1752_CR1","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","volume":"9","author":"P Kaye","year":"2011","unstructured":"Kaye P, Scott P. Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol. 2011;9(8):604\u201315.","journal-title":"Nat Rev Microbiol"},{"key":"1752_CR2","first-page":"251","volume":"3","author":"R Kumar","year":"2012","unstructured":"Kumar R, Nylen S. Immunobiology of visceral leishmaniasis. Front Immunol. 2012;3:251.","journal-title":"Front Immunol"},{"key":"1752_CR3","first-page":"198","volume":"4","author":"LM Deane","year":"1962","unstructured":"Deane LM, Deane MP. Visceral leishmaniasis in Brazil: geographical distribution and trnsmission. Rev Inst Med Trop Sao Paulo. 1962;4:198\u2013212.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"1-2","key":"1752_CR4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.vetpar.2015.01.003","volume":"208","author":"L Gradoni","year":"2015","unstructured":"Gradoni L. Canine Leishmania vaccines: still a long way to go. Vet Parasitol. 2015;208(1-2):94\u2013100.","journal-title":"Vet Parasitol"},{"issue":"3","key":"1752_CR5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/1568008023340631","volume":"2","author":"J Mauel","year":"2002","unstructured":"Mauel J. Vaccination against Leishmania infections. Curr Drug Targets Immune Endocr Metabol Disord. 2002;2(3):201\u201326.","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"issue":"3","key":"1752_CR6","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1371\/journal.pntd.0000965","volume":"5","author":"CH Costa","year":"2011","unstructured":"Working Group on Research Priorities for Development of Leishmaniasis V, Costa CH, Peters NC, Maruyama SR, de Brito Jr EC, Santos IK. Vaccines for the leishmaniases: proposals for a research agenda. PLoS Negl Trop Dis. 2011;5(3):e943.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"1752_CR7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.vaccine.2011.11.005","volume":"30","author":"MS Duthie","year":"2012","unstructured":"Duthie MS, Raman VS, Piazza FM, Reed SG. The development and clinical evaluation of second-generation leishmaniasis vaccines. Vaccine. 2012;30(2):134\u201341.","journal-title":"Vaccine"},{"issue":"7","key":"1752_CR8","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","volume":"71","author":"EA Coelho","year":"2003","unstructured":"Coelho EA, Tavares CA, Carvalho FA, Chaves KF, Teixeira KN, Rodrigues RC, et al. Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infect Immun. 2003;71(7):3988\u201394.","journal-title":"Infect Immun"},{"issue":"9","key":"1752_CR9","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.micinf.2007.05.012","volume":"9","author":"FH Zanin","year":"2007","unstructured":"Zanin FH, Coelho EA, Tavares CA, Marques-da-Silva EA, Silva Costa MM, Rezende SA, et al. Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections. Microbes Infect. 2007;9(9):1070\u20137.","journal-title":"Microbes Infect"},{"issue":"46","key":"1752_CR10","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1016\/j.vaccine.2008.05.095","volume":"26","author":"AP Fernandes","year":"2008","unstructured":"Fernandes AP, Costa MM, Coelho EA, Michalick MS, de Freitas E, Melo MN, et al. Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein. Vaccine. 2008;26(46):5888\u201395.","journal-title":"Vaccine"},{"issue":"9-10","key":"1752_CR11","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","volume":"19","author":"VO Silva da","year":"2000","unstructured":"da Silva VO, Borja-Cabrera GP, Correia Pontes NN, de Souza EP, Luz KG, Palatnik M, et al. A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN). Vaccine. 2000;19(9-10):1082\u201392.","journal-title":"Vaccine"},{"issue":"27-28","key":"1752_CR12","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","volume":"20","author":"GP Borja-Cabrera","year":"2002","unstructured":"Borja-Cabrera GP, Correia Pontes NN, da Silva VO, Paraguai de Souza E, Santos WR, Gomes EM, et al. Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN). Vaccine. 2002;20(27-28):3277\u201384.","journal-title":"Vaccine"},{"issue":"12","key":"1752_CR13","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.vaccine.2006.11.057","volume":"25","author":"LE Parra","year":"2007","unstructured":"Parra LE, Borja-Cabrera GP, Santos FN, Souza LO, Palatnik-de-Sousa CB, Menz I. Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil. Vaccine. 2007;25(12):2180\u20136.","journal-title":"Vaccine"},{"key":"1752_CR14","doi-asserted-by":"crossref","unstructured":"Fernandes AP, Coelho EA, Machado-Coelho GL, Grimaldi G Jr, Gazzinelli RT. Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives. Curr Opin Microbiol. 2012;15(4):476-85.","DOI":"10.1016\/j.mib.2012.05.002"},{"key":"1752_CR15","first-page":"439","volume":"123","author":"R Garg","year":"2006","unstructured":"Garg R, Dube A. Animal models for vaccine studies for visceral leishmaniasis. Indian J Med Res. 2006;123:439\u201354.","journal-title":"Indian J Med Res"},{"issue":"44","key":"1752_CR16","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1016\/j.vaccine.2007.08.009","volume":"25","author":"RC Giunchetti","year":"2007","unstructured":"Giunchetti RC, Correa-Oliveira R, Martins-Filho OA, Teixeira-Carvalho A, Roatt BM, de Oliveira Aguiar-Soares RD, et al. Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs. Vaccine. 2007;25(44):7674\u201386.","journal-title":"Vaccine"},{"issue":"3-4","key":"1752_CR17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.vetpar.2013.09.011","volume":"198","author":"LA Resende","year":"2013","unstructured":"Resende LA, Roatt BM, Aguiar-Soares RD, Viana KF, Mendon\u00e7a LZ, Lanna MF, et al. Cytokine and nitric oxide patterns in dogs immunized with LBSap vaccine, before and after experimental challenge with Leishmania chagasi plus saliva of Lutzomyia longipalpis. Vet Parasitol. 2013;198(3-4):371\u201381.","journal-title":"Vet Parasitol"},{"issue":"11","key":"1752_CR18","doi-asserted-by":"crossref","first-page":"e49780","DOI":"10.1371\/journal.pone.0049780","volume":"7","author":"BM Roatt","year":"2012","unstructured":"Roatt BM, Aguiar-Soares RD, Vitoriano-Souza J, Coura-Vital W, Braga SL, Correa-Oliveira R, et al. Performance of LBSap vaccine after intradermal challenge with L. infantum and saliva of Lu. longipalpis: immunogenicity and parasitological evaluation. PLoS One. 2012;7(11):e49780.","journal-title":"PLoS One"},{"issue":"4","key":"1752_CR19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.exppara.2011.05.011","volume":"128","author":"JM Arantes","year":"2011","unstructured":"Arantes JM, Francisco AF, de Abreu Vieira PM, Silva M, Ara\u00fajo MS, de Carvalho AT, Pedrosa ML, Carneiro CM, Tafuri WL, Martins-Filho OA, El\u00f3i-Santos SM. Trypanosoma cruzi: desferrioxamine decreases mortality and parasitemia in infected mice through a trypanostatic effect. Exp Parasitol. 2011;128(4):401\u20138.","journal-title":"Exp Parasitol"},{"issue":"4","key":"1752_CR20","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/CDLI.8.4.828-831.2001","volume":"8","author":"S Bretagne","year":"2001","unstructured":"Bretagne S, Durand R, Olivi M, Garin JF, Sulahian A, Rivollet D, et al. Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice. Clin Diagn Lab Immunol. 2001;8(4):828\u201331.","journal-title":"Clin Diagn Lab Immunol"},{"key":"1752_CR21","unstructured":"Health Brazil Ministry. Manual de Vigil\u00e2ncia e Controle da Leishmaniose Visceral Bras\u00edlia, Brazil. http:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/manual_vigilancia_controle_leishmaniose_visceral_1edicao.pdf . Acessed 22 Feb 2016."},{"issue":"1","key":"1752_CR22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/08830185.2010.529976","volume":"30","author":"H Kumar","year":"2011","unstructured":"Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol. 2011;30(1):16\u201334.","journal-title":"Int Rev Immunol"},{"issue":"5891","key":"1752_CR23","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.1159194","volume":"321","author":"NC Peters","year":"2008","unstructured":"Peters NC, Egen JG, Secundino N, Debrabant A, Kimblin N, Kamhawi S, et al. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science. 2008;321(5891):970\u20134.","journal-title":"Science"},{"key":"1752_CR24","doi-asserted-by":"crossref","unstructured":"Rousseau D, Demartino S, Ferrua B, Michiels JF, Anjuere F, Fragaki K, et al. In vivo involvement of polymorphonuclear neutrophils in Leishmania infantum infection. BMC Microbiol. 2001;1:1:17.","DOI":"10.1186\/1471-2180-1-17"},{"issue":"2","key":"1752_CR25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/IAI.01388-07","volume":"76","author":"E McFarlane","year":"2008","unstructured":"McFarlane E, Perez C, Charmoy M, Allenbach C, Carter KC, Alexander J, et al. Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani. Infect Immun. 2008;76(2):532\u201341.","journal-title":"Infect Immun"},{"issue":"1-2","key":"1752_CR26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.vetimm.2011.02.007","volume":"141","author":"MS Araujo","year":"2011","unstructured":"Araujo MS, de Andrade RA, Sathler-Avelar R, Magalhaes CP, Carvalho AT, Andrade MC, et al. Immunological changes in canine peripheral blood leukocytes triggered by immunization with first or second generation vaccines against canine visceral leishmaniasis. Vet Immunol Immunopathol. 2011;141(1-2):64\u201375.","journal-title":"Vet Immunol Immunopathol"},{"issue":"2-3","key":"1752_CR27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jcpa.2006.06.005","volume":"135","author":"RC Giunchetti","year":"2006","unstructured":"Giunchetti RC, Mayrink W, Genaro O, Carneiro CM, Correa-Oliveira R, Martins-Filho OA, et al. Relationship between canine visceral leishmaniosis and the Leishmania (Leishmania) chagasi burden in dermal inflammatory foci. J Comp Pathol. 2006;135(2-3):100\u20137.","journal-title":"J Comp Pathol"},{"issue":"2","key":"1752_CR28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/exmp.2002.2418","volume":"72","author":"AC Cunningham","year":"2002","unstructured":"Cunningham AC. Parasitic adaptive mechanisms in infection by Leishmania. Exp Mol Pathol. 2002;72(2):132\u201341.","journal-title":"Exp Mol Pathol"},{"issue":"2","key":"1752_CR29","first-page":"1","volume":"69","author":"C Bogdan","year":"2012","unstructured":"Bogdan C. Natural killer cells in experimental and human leishmaniasis. Front Cell Infect Microbiol. 2012;69(2):1\u20139.","journal-title":"Front Cell Infect Microbiol"},{"issue":"5-6","key":"1752_CR30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0264-410X(02)00407-3","volume":"21","author":"MT Esser","year":"2003","unstructured":"Esser MT, Marchese RD, Kierstead LS, Tussey LG, Wang F, Chirmule N, et al. Memory T cells and vaccines. Vaccine. 2003;21(5-6):419\u201330.","journal-title":"Vaccine"},{"issue":"1-2","key":"1752_CR31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.vetimm.2007.07.009","volume":"121","author":"RC Giunchetti","year":"2008","unstructured":"Giunchetti RC, Martins-Filho OA, Carneiro CM, Mayrink W, Marques MJ, Tafuri WL, et al. Histopathology, parasite density and cell phenotypes of the popliteal lymph node in canine visceral leishmaniasis. Vet Immunol Immunopathol. 2008;121(1-2):23\u201333.","journal-title":"Vet Immunol Immunopathol"},{"issue":"3","key":"1752_CR32","first-page":"1","volume":"80","author":"J Alexander","year":"2012","unstructured":"Alexander J, Brombacher F. T helper1\/t helper2 cells and resistance\/susceptibility to leishmania infection: is this paradigm still relevant? Front Immunol. 2012;80(3):1\u201313.","journal-title":"Front Immunol"},{"issue":"20-21","key":"1752_CR33","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/S0264-410X(99)00058-4","volume":"17","author":"WR Santos","year":"1999","unstructured":"Santos WR, Paraguai de Souza E, Palatnik M, Palatnik de Sousa CB. Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani. Vaccine. 1999;17(20-21):2554\u201361.","journal-title":"Vaccine"},{"key":"1752_CR34","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.vaccine.2013.12.046","volume":"32","author":"CB Fernandes","year":"2014","unstructured":"Fernandes CB, Junior JTM, Jesus C, Souza BMPS, Larangeira DF, Fraga DBM, et al. Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnoses. Vaccine. 2014;32:1287\u201395.","journal-title":"Vaccine"},{"issue":"6","key":"1752_CR35","doi-asserted-by":"crossref","first-page":"e38859","DOI":"10.1371\/journal.pone.0038859","volume":"7","author":"L Sanchez-Sampedro","year":"2012","unstructured":"Sanchez-Sampedro L, Gomez CE, Mejias-Perez E, Sorzano CO, Esteban M. High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK\/MVA-LACK regimen in Leishmania major BALB\/c model of infection. PLoS One. 2012;7(6):e38859.","journal-title":"PLoS One"},{"issue":"3","key":"1752_CR36","doi-asserted-by":"crossref","first-page":"e33161","DOI":"10.1371\/journal.pone.0033161","volume":"7","author":"K Kedzierska","year":"2012","unstructured":"Kedzierska K, Curtis JM, Valkenburg SA, Hatton LA, Kiu H, Doherty PC, et al. Induction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses. PLoS One. 2012;7(3):e33161.","journal-title":"PLoS One"},{"issue":"9","key":"1752_CR37","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/IAI.00394-07","volume":"75","author":"RN Coler","year":"2007","unstructured":"Coler RN, Goto Y, Bogatzki L, Raman V, Reed SG. Leish-111f, a recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4+ T cells. Infect Immun. 2007;75(9):4648\u201354.","journal-title":"Infect Immun"},{"issue":"5","key":"1752_CR38","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.4049\/jimmunol.1202801","volume":"190","author":"R Dey","year":"2013","unstructured":"Dey R, Dagur PK, Selvapandiyan A, McCoy JP, Salotra P, Duncan R, et al. Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB\/c mice.J Immunol. 2013;190(5):2138\u201349.","journal-title":"J Immunol"},{"issue":"2","key":"1752_CR39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.vaccine.2014.11.039","volume":"33","author":"JA Fiuza","year":"2015","unstructured":"Fiuza JA, Gannavaram S, Santiago Hda C, Selvapandiyan A, Souza DM, Passos LS, et al. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum. Vaccine. 2015;33(2):280\u20138.","journal-title":"Vaccine"},{"key":"1752_CR40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2180-14-8","volume":"14","author":"S Bhowmick","year":"2014","unstructured":"Bhowmick S, Ravindran R, Ali N. IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccine. BMC Microbiol. 2014;14:8.","journal-title":"BMC Microbiol"},{"issue":"6","key":"1752_CR41","first-page":"238","volume":"119","author":"A Awasthi","year":"2004","unstructured":"Awasthi A, Mathur RK, Saha B. Immune response to Leishmania infection. Indian J Med Res. 2004;119(6):238\u201358.","journal-title":"Indian J Med Res"},{"issue":"2","key":"1752_CR42","first-page":"547","volume":"27","author":"CB Palatnik-de-Sousa","year":"1994","unstructured":"Palatnik-de-Sousa CB, Paraguai-de-Souza E, Gomes EM, Borojevic R. Experimental murine Leishmania donovani infection: immunoprotection by the fucose-mannose ligand (FML). Braz J Med Biol Res. 1994;27(2):547\u201351.","journal-title":"Braz J Med Biol Res"},{"issue":"1-2","key":"1752_CR43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0264-410X(01)00322-X","volume":"20","author":"A Ghosh","year":"2001","unstructured":"Ghosh A, Zhang WW, Matlashewski G. Immunization with A2 protein results in a mixed Th1\/Th2 and a humoral response which protects mice against Leishmania donovani infections. Vaccine. 2001;20(1-2):59\u201366.","journal-title":"Vaccine"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-016-1752-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T16:57:04Z","timestamp":1601053024000},"score":1,"resource":{"primary":{"URL":"http:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-016-1752-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,30]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1752"],"URL":"https:\/\/doi.org\/10.1186\/s13071-016-1752-6","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,30]]},"article-number":"472"}}